Business Description
COMPASS Pathways is a UK-based mental health company working to bring new treatment options to patients who have not responded well to existing therapies. Its lead product, COMP360, is a psilocybin-based treatment currently in late-stage trials for treatment-resistant depression, with earlier-stage studies also underway for PTSD and anorexia nervosa. The company operates across the United Kingdom and the United States and is headquartered in London.
